Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Comparing two methods for treating blocked stomach openings

Official title: A Randomized Trial Comparing Endoscopic UltraSound-guided GasTrojejunostomy (EUS-GJ) and Surgical GastrojejunOstomy (S-GJ) for the Management of Malignant gastRic outlEt Obstruction

Run by AdventHealth · NCT06128018 · Data updated 2026-11-12

This study is testing which of two procedures, one done with an endoscope and the other through surgery, is safer and works better for people with blocked stomach openings caused by cancer.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment70 (estimated)
SponsorAdventHealth
Academic / other
Locations1 site (Orlando, Florida)
StatusRecruiting
StartedNovember 1, 2023
Main results expectedSeptember 8, 2026
Study endsMarch 8, 2027
Registry record updatedSeptember 4, 2026
Trial IDNCT06128018 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older with evidence of an obstructing neoplasm in the distal stomach or duodenum.

Probably not a fit

Patients with a poor prognosis or those who are candidates for potential surgical resection of their cancer may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study aims to compare the outcomes of two procedures for managing malignant gastric outlet obstruction: Endoscopic Ultrasound-guided gastrojejunostomy (EUS-GJ) and Surgical gastrojejunostomy (S-GJ). Participants will be randomly assigned to one of the two procedures and will be monitored for up to 12 months to assess the rates of procedure-related adverse events. The study seeks to determine which method is safer and more effective for patients with this condition.

Why it matters

Potential benefit: If successful, this study could provide insights into the safer and more effective management of malignant gastric outlet obstruction.

How similar studies have gone: While similar studies have explored gastrojejunostomy techniques, this specific comparison of EUS-GJ and S-GJ is novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. ≥ 18 years of age.
2. Radiographic OR Endoscopic evidence of an obstructing neoplasm in the distal stomach or duodenum.
3. GOOSS of 0 or 1
4. BOTH surgical and endoscopic GJ are technically and clinically feasible
5. Can understand and is willing to sign informed consent form prior to the initiation of any study procedures (or when applicable the subject's LAR).

Exclusion Criteria:

1. \< 18 years of age
2. ECOG \>2
3. Expected survival (determined by the treating oncologist) is less than 2 months.
4. Candidates for potential resection of the cancer and obstructed anatomical area (this includes patients with borderline resectable pancreatic cancer)
5. Peritoneal carcinomatosis with associated bowel obstruction on imaging or during laparoscopy
6. Large volume ascites (patients with moderate volume ascites may undergo IR guided drainage prior to randomization)
7. Anatomical factors that technically hinder EUS-GJ OR Surgical-GJ (diffuse tumor involvement in path of LAMS or surgery, surgically altered anatomy that interferes with the ability to perform an anastomosis etc)
8. Pregnancy

Where it's running

  • AdventHealth Orlando
    Orlando, Florida, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.